TrialBlood advances2021
A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention.
Lia Perez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
TrialBlood advances2021
Lia Perez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.